	US 11,965,004 B2
	Molecular guide system peptides and uses thereof
Kathlynn C. Brown, Staunton, VA (US); Nathan Collins, Menlo Park, CA (US); Shunzi “Susan” Li, Harrisonburg, VA (US); Curtis Allred, Menlo Park, CA (US); Keen Chung, Menlo Park, CA (US); and Michael McGuire, Menlo Park, CA (US)
Assigned to SRI International, Menlo Park, CA (US)
Appl. No. 16/629,799
Filed by SRI INTERNATIONAL, Menlo Park, CA (US)
PCT Filed Jul. 10, 2018, PCT No. PCT/US2018/041403 § 371(c)(1), (2) Date Jan. 9, 2020, PCT Pub. No. WO2019/014190, PCT Pub. Date Jan. 17, 2019.
Claims priority of provisional application 62/530,633, filed on Jul. 10, 2017.
Prior Publication US 2022/0227823 A1, Jul. 21, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 14/47 (2006.01); A61K 47/64 (2017.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); A61K 38/00 (2006.01)

CPC C07K 14/4702 (2013.01) [A61K 47/64 (2017.08); A61P 35/00 (2018.01); C07K 16/2803 (2013.01); A61K 38/00 (2013.01)]

13 Claims

1. A composition comprising an antibody conjugated to one or more molecular guidance system (MGS) peptides, directly or via a linker, wherein the one or more MGS peptides are selected from the group consisting of SEQ ID NOs: 2, 3, 20-22, and 38-41.